Engineering GID4 for use as an N‐terminal proline binder via directed evolution
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.28868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Svetlana P Ikonomova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Bioscience and Biotechnology Research (IBBR), National Institute of Standards and Technology (NIST) and the University of Maryland (UMD…. Hauptthemen laut MEDLINE: Proline, Directed Molecular Evolution, Protein Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Institute of Standards and Technology (NIST) National Research Council (NRC) Post-doctoral Fellowship.
Abstract (Originalsprache)
Nucleic acid sequencing technologies have gone through extraordinary advancements in the past several decades, significantly increasing throughput while reducing cost. To create similar advancement in proteomics, numerous approaches are being investigated to advance protein sequencing. One of the promising approaches uses N‐terminal amino acid binders (NAABs), also referred to as recognizers, that selectively can identify amino acids at the N‐terminus of a peptide. However, there are only a few engineered NAABs currently available that bind to specific amino acids and meet the requirements of a biotechnology reagent. Therefore, additional NAABs need to be identified and engineered to enable confident identification and, ultimately, de novo protein sequencing. To fill this gap, a human protein GID4 was engineered to create a NAAB for N‐terminal proline (Nt‐Pro). While native GID4 binds Nt‐Pro, its binding is weak (µmol/L) and greatly influenced by the identity of residues following the Nt‐Pro. Through directed evolution, yeast‐surface display, and fluorescence‐activated cell sorting, we identified sequence variants of GID4 with increased binding response to Nt‐Pro. Moreover, variants with an A252V mutation showed a reduced influence from residues in the second and third positions of the target peptide when binding to Nt‐Pro. The workflow outlined here is shown to be a viable strategy for engineering NAABs, even when starting from native Nt‐binding proteins whose binding is strongly impacted by the identity of residues following Nt‐amino acid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Bioscience and Biotechnology Research (IBBR), National Institute of Standards and Technology (NIST) and the University of Maryland (UMD), Rockville, Maryland, USA.
- New England Biolabs Inc, Ipswich, Massachusetts, USA.
- Biomolecular Labeling Laboratory, Institute for Bioscience and Biotechnology Research (IBBR), Rockville, Maryland, USA.
ORCID-Profile: Svetlana P Ikonomova, John P Marino
Förderung
- National Institute of Standards and Technology (NIST) National Research Council (NRC) Post-doctoral Fellowship
Zitieren
APA
Ikonomova, S. P., Yan, B., Sun, Z., Lyon, R. B., Zatopek, K. M., Marino, J. P., & Kelman, Z. (2025). Engineering GID4 for use as an N‐terminal proline binder via directed evolution. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28868
Vancouver
Ikonomova SP, Yan B, Sun Z, Lyon RB, Zatopek KM, Marino JP, et al. Engineering GID4 for use as an N‐terminal proline binder via directed evolution. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.28868
BibTeX
@article{Ikonomova2025,
author = {Ikonomova, Svetlana P and Yan, Bo and Sun, Zhiyi and Lyon, Rachel B and Zatopek, Kelly M and Marino, John P and Kelman, Zvi},
title = {Engineering GID4 for use as an N‐terminal proline binder via directed evolution},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.28868}
}
EUVIMED